111 Net Profit Margin 2018-2024 | YI
111 net profit margin from 2018 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| 111 Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-12-31 | $1.97B | $-0.01B | -0.46% |
| 2024-09-30 | $2.06B | $-0.04B | -1.75% |
| 2024-06-30 | $2.05B | $-0.05B | -2.30% |
| 2024-03-31 | $2.06B | $-0.05B | -2.58% |
| 2023-12-31 | $2.11B | $-0.06B | -2.66% |
| 2023-09-30 | $2.09B | $-0.04B | -1.97% |
| 2023-06-30 | $2.05B | $-0.04B | -2.04% |
| 2023-03-31 | $2.03B | $-0.05B | -2.37% |
| 2022-12-31 | $1.96B | $-0.06B | -3.06% |
| 2022-09-30 | $1.96B | $-0.06B | -3.27% |
| 2022-06-30 | $2.01B | $-0.09B | -4.43% |
| 2022-03-31 | $2.02B | $-0.10B | -4.94% |
| 2021-12-31 | $1.95B | $-0.11B | -5.39% |
| 2021-09-30 | $1.84B | $-0.11B | -5.92% |
| 2021-06-30 | $1.67B | $-0.09B | -5.15% |
| 2021-03-31 | $1.43B | $-0.07B | -5.17% |
| 2020-12-31 | $1.26B | $-0.07B | -5.56% |
| 2020-09-30 | $0.99B | $-0.07B | -6.94% |
| 2020-06-30 | $0.80B | $-0.07B | -8.74% |
| 2020-03-31 | $0.69B | $-0.07B | -10.39% |
| 2019-12-31 | $0.57B | $-0.07B | -12.68% |
| 2019-09-30 | $0.45B | $-0.07B | -15.21% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.064B | $1.973B |
| 111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.774B | 53.56 |
| Hims & Hers Health (HIMS) | United States | $11.630B | 121.74 |
| Tempus AI (TEM) | United States | $10.119B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.616B | 72.12 |
| IRhythm Technologies (IRTC) | United States | $4.348B | 0.00 |
| Privia Health (PRVA) | United States | $2.829B | 212.00 |
| Enovis (ENOV) | United States | $1.955B | 12.10 |
| Clover Health Investments (CLOV) | United States | $1.926B | 0.00 |
| Schrodinger (SDGR) | United States | $1.732B | 0.00 |
| Phreesia (PHR) | United States | $1.434B | 0.00 |
| Azenta (AZTA) | United States | $1.154B | 53.74 |
| Omnicell (OMCL) | United States | $1.154B | 20.35 |
| 10x Genomics (TXG) | United States | $1.016B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.568B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.530B | 0.00 |
| Talkspace (TALK) | United States | $0.512B | 152.00 |
| Veradigm (MDRX) | United States | $0.466B | 0.00 |
| Standard BioTools (LAB) | United States | $0.387B | 0.00 |
| TruBridge (TBRG) | United States | $0.381B | 850.00 |
| Claritev (CTEV) | United States | $0.344B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.279B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.215B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.200B | 0.00 |
| Pulmonx (LUNG) | United States | $0.148B | 0.00 |
| American Well (AMWL) | United States | $0.106B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.094B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.092B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.081B | 0.00 |
| CareCloud (CCLD) | United States | $0.080B | 3.03 |
| HeartBeam (BEAT) | United States | $0.063B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.062B | 0.00 |
| Outset Medical (OM) | United States | $0.042B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.015B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |